Thiol/disulphide homeostasis in intensive care unit patients with sepsis and septic shock

Background/aim: Sepsis is a condition caused by infection followed by unregulated inflammatory response which may lead to organ dysfunction. The aim of this study is to be the first in the literature and it has been designed to show the thiol/disulphide changes in patients with sepsis and septic shock and their correlation with acute phase reactants. Material and methods: A total of 113 patients septic shock 53 and sepsis 60 and 60 healthy control subjects have been enrolled in this study from the period February 2018 to 2019. The patients were divided in 2 groups: nonsurvivors 74 and survivors 39 . The investigation includes measurements of native thiol, total thiol, dynamic disulphide bond, oxidized thiol ratio, reduced thiol ratio and thiol oxidation reduction ratio, erythrocyte sedimentation rate, C-reactive protein, and procalcitonin. Results: The findings of this study suggest that changes in thiol levels play a role in the pathogenesis of patients with sepsis and septic shock. Conclusions: Thiol/disulphide homeostasis is impaired in patients with sepsis and septic shock. Understanding the role of thiol/ disulphide homeostasis in sepsis and septic shock may provide different therapeutic intervention strategies for patients.

___

  • 1. Singer M, Deutschman CS, Swymour CW, Shankar-Hari M, Annane D et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Journal of the American Medical Association 2016 23;315(8):801-10. doi: 10.1001/ jama.2016.0287
  • 2. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Critical Care Medicine 2006;34(1):15-21.
  • 3. Karapetsa M, Pitsika M, Goutzourelas N, Stagos D, Tousia BA et al. Oxidative status in ICU patients with septic shock. Food Chemical Toxicolology 2013; 61:106-11. doi: 10.1016/j. fct.2013.03.026
  • 4. Stadtman ER, Levine RL. Protein oxidation. Annals of New York Academy Sciences 2000; 899(1): 191-208. doi: 10.1111/ j.1749-6632.2000.tb06187.x
  • 5. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21(3):361-70.
  • 6. Schunmacker PT. Lung cell hypoxia: role of mitochondrial reactive oxygen species signaling in trigerring responses. Proceedings of the American Thoracic Society 2011; 8(6):477- 84. doi: 10.1513/pats.201103-032MW
  • 7. Hecker M, Cattaruzza M, Wagner AH. Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells. General Pharmacolology 1999; 32(1):9-16.
  • 8. Gümüşyayla S, Vural G, Bektaş H, Neşelioğlu S, Deniz O et al. Evaluation of dynamic thiol-disulphide homeostasis in patients with epilepsy. Epilepsia 2016;22 (3):86-92
  • 9. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clinical Biochemistry 2014; 47(18):326-32. doi: 10.1016/j.clinbiochem.2014.09.026
  • 10. Lorente L, Martin MM, Perez-Cejas A, Abreu-González P, Lopez RO et al. Serum total antioxidant capacity during the first week of sepsis and mortality. Journal of Critical Care 2018; 47:139-144. doi: 10.1016/j.jcrc.2018.06.025
  • 11. Lorente L, Martin MM, Almeida T, Abreu-González, Ferreres J et al. Association between serum total antioxidant capacity and mortality in severe septic patients. Journal of Critical Care 2015; 30(1):217.e7-12. doi: 10.1016/j.jcrc.2014.09.012
  • 12. Kumar S, Grupta E, Kaushik S, Kumar Srivasrava V, Mehta SK et al. Evaluation of oxidative stres and antioxidant status: Correlation with the severity of sepsis. Scandinavian Journal of Immunology 2018;87(4):e12653. doi: 10.1111/sji.12653
  • 13. Shankar-Hari M, Phillips GS, Levy ML, Levy ML, Seymour CW et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal of the American Medical Association 2016 23;315(8):775-87. doi: 10.1001/jama.2016.0289
  • 14. Healthcare Cost and Utilization Project. USA: HCUP-US, 2019. 15. Baykara AR, Tuzcu A, Omma A, Acet GK, Dogan E et al. Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method. Northern Clinics of Istanbul 2018;6(4):348-354. doi: 10.14744/nci.2018.37132
  • 16. Dirican N, Dirican A, Sen O, Aynali A, Atalay S et al. Thiol/ disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Report 2016;21(5):197-203. doi: 10.1179/1351000215Y.0000000027
  • 17. Tuzcu A, Baykara RA, Omma A, Acet GK, Dogan E et al. Thiol/ Disulfide homeostasis in patients with rheumatoid arthritis. Romanian Journal of Internal Medicine 2019;57(1):30-36. doi: 10.2478/rjim-2018-0025
  • 18. Eren MA, Koyuncu I, Incebiyik H, Karakaş H, Erel Ö et al. The evaluation of thiol/disulfide homeostasis in a diabetic nephropathy. Turkish Journal Endocrinology Metabolism 2019;148:249-253. doi: 10.1016/j.diabres.2019.01.022
  • 19. Ozcan O, Erdal H, Ilhan G, Demir D, Gurpinar AB et al. Plasma Ischemia-modified albumin levels and dynamic thiol/disulfide balance in sickle cell disease: A case control. Turkish Journal of Hematology 2018;35(4):265-270. doi: 10.4274/tjh.2018.0119
  • 20. Hizal M, Sendur MAN, Bilgin B, Akinci MB, Dede DS et al. Evaluation of dynamic thiol/disulphide homeostasis in locally advanced and metastatic gastric cancer. Journal of Oncological Sciences 2018;4(1):1-4.
  • 21. Antinel AE, Erel O, Yazilitas F, Bulbul M, Oguz MM et al. Changes in thiol/disulfide homeostasis in juvenile idiopathic arthritis. Pediatrisc International 2018;60(6):593-596. doi: 10.1111/ped.13569
  • 22. Benton SM, Liang Z, Hao L, Liang Y, Hebbar G et al. Differential of tissue thiol-disulphide redox status in murine model of peritonitis. Journal of Inflammation-London 2012;9(1):36. doi: 10.1186/1476-9255-9-36
  • 23. Ayar G, Sahin S, Men AY, Yazici MU, Neselioglu S et al. Thiol-disulphide homeostasis is an oxidative stress indicator in critically ill children with sepsis. Archivos Argentinos de Pediatria 2019;117(3):143-148. doi: 10.5546/aap.2019.eng.143
  • 24. Kumar S, Grupta E, Kaushik S, Kumar SV, Mehta SK et al. Evaluation of oxidative stres and antioxidant status: correlation with the severity of sepsis. Scandinavian Journal of Immunology 2018;87(4):e12653. doi: 10.1111/sji.12653
  • 25. Waheeda N, Ibrahim MD, Ahammed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. International Journal of Critical Illness & Injury Science 2014;4(3):195-9. doi: 10.4103/2229-5151.141356